Table 2.
Baseline echocardiographic variables of patients with progression, stabilisation and regression of rheumatic heart disease at 2-year follow-up
Valve | Variable* | Progressed: borderline to definite (N=29) | Remained definite (N=11) | Regressed/stable (borderline)/other (N=156) |
Mitral valve, N (%) | Anterior leaflet thickening† | 18 (62.1) | 10 (90.9) | 103 (65.6) |
Chordal thickening | 0 | 2 (18.2) | 0 | |
Restricted leaflet motion | 1 (3.4) | 4 (36.4) | 4 (2.5) | |
Excessive leaflet tip motion | 2 (6.9) | 6 (54.5) | 20 (12.7) | |
Mitral stenosis | 0 | 0 | 0 | |
Any regurgitation | 28 (96.6) | 11 (100) | 141 (90.4) | |
Regurgitation seen in two views | 26 (89.7) | 10 (90.9) | 141 (90.4) | |
Jet length ≥2 cm‡ | 25 (86.2) | 9 (81.8) | 116 (74.4) | |
Velocity ≥3 m/s for one envelope§ | 9 (31.0) | 4 (36.4) | 32 (20.5) | |
Pansystolic jet (colour Doppler) | 15 (51.7) | 8 (72.7) | 99 (63.5) | |
Aortic valve, N (%) | Irregular or focal thickening | 0 | 2 (18.2) | 1 (0.6) |
Coaptation defect | 0 | 1 (9.1) | 2 (1.3) | |
Restricted leaflet motion | 0 | 0 | 0 | |
Leaflet prolapse | 0 | 0 | 0 | |
Any regurgitation | 2 (6.9) | 3 (27.3) | 32 (20.5) | |
Regurgitation seen in two views | 2 (6.9) | 2 (18.2) | 28 (17.9) | |
Jet length ≥1 cm‡ | 1 (3.5) | 3 (27.3) | 29 (18.6) | |
Velocity ≥3 m/s in early diastole§ | 0 | 1 (9.1) | 6 (3.9) | |
Pandiastolic jet (colour Doppler) | 0 | 2 (18.2) | 20 (12.8) |
** Congenital mitral valve or aortic valve abnormalities were excluded.
† Abnormal thickening of the anterior mitral valve leaflet ≥3 or >4 mm using harmonic imaging.
‡ In at least 1 view.
§ Measurements available with the Vivid-Q exams.